Roughly 12% of the world’s total cancer cases in 2024 were likely caused by an infection, according to new research published in The Lancet Oncology. New research from the World Health Organization linked 2.3 million new cancer cases to an infection.
Global Burden Linked to Five Specific Pathogens
Most infection-driven diagnoses stem from just five pathogens. Helicobacter pylori and human papillomavirus (HPV) were the two leading causes of the cases. Hepatitis B follows at 2%, the Epstein-Barr virus at 1%, and hepatitis C at under 1%. These infections contribute to more than 20 different types of malignancies, ranging from stomach and liver cancers to blood and cervical cancers.
However, the underlying data requires careful interpretation. Seth Schneider, a health columnist for the Bonner County Daily Bee, noted that the 2.3 million cases were not identified one by one as direct clinical findings. Instead, researchers calculated the figures by applying previously accepted causal relationships to global cancer incidence estimates. Consequently, regional variations are sharp. While the global average sits at 12%, Medical Daily noted that the International Agency for Research on Cancer estimated North American infection-attributable cancers at around 5%. In contrast, sub-Saharan Africa reaches 25% and eastern Asia accounts for 42%.
Biological Mechanisms Connecting Pathogens to Tumors
Viruses drive oncogenesis through direct genetic alteration. ZME Science outlined three main pathways: inactivating cell suicide proteins like TP53, inserting viral DNA directly into host cell genomes to disrupt cell division controls, and introducing foreign oncogenes. Bacteria and parasites operate more indirectly by triggering chronic inflammation. Long-term immune overactivity damages surrounding tissues, leading to critical DNA errors as the body attempts rapid cell repair.
This framework creates diagnostic complexities, particularly with ubiquitous pathogens. Epstein-Barr virus infects the vast majority of adults worldwide, yet associated cancers remain statistically uncommon. As the Bonner County Daily Bee pointed out, this disparity highlights the role of individual immune function and long-term viral persistence over simple presence.
Vaccination and Treatment Gaps in Low-Income Nations
Preventative tools remain highly effective where accessible. In Australia, an HPV vaccination program launched in 2007 drove infections down by 90% among eligible groups, putting the country on track to eliminate cervical cancer by 2035. Yet equity issues persist globally. ZME Science noted that roughly 75% of infection-related cancers occur in low- and middle-income countries, where screenings, condoms, and antiviral treatments face severe infrastructure limits.
Did You Know?
While historical WHO studies tracked infection-attributable cancer proportions from a peak of 18% in 2002 down to current levels, authors of the latest Lancet Oncology study caution that data quality and sources have shifted too much over decades to make direct historical comparisons.
Frequently Asked Questions About Pathogen-Driven Cancers
Why do most people with Epstein-Barr virus or H. pylori never develop cancer?
Most carriers control these infections through healthy immune function without developing malignancies. The Bonner County Daily Bee reported that chronic inflammation, immune suppression, and long-term tissue stress are required to push infected cells down the road toward cancerous mutations.
How much do federal vaccine recommendations impact HPV and Hepatitis B prevention rates?
Federal policy changes create distinct public health hurdles. Medical Daily reported that a Centers for Disease Control and Prevention schedule change altered standard childhood vaccine recommendations, though ongoing federal court proceedings and appeals mean families must confirm current regional guidance directly with local health departments or pediatricians.
What are the primary drivers of infection-linked cancer cases in the United States?
According to Medical Daily and data from the International Agency for Research on Cancer, Helicobacter pylori and human papillomavirus represent the two leading infectious drivers of new cancer cases domestically and worldwide.
Keep reading